Department of Breast Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, 110042, Liaoning Province, China.
Department of Breast Surgery, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China.
Asian J Surg. 2022 Jan;45(1):89-96. doi: 10.1016/j.asjsur.2021.03.020. Epub 2021 Apr 27.
The regression of positive nodes in breast cancer after neoadjuvant chemotherapy (NAC) remains unknown. This study aimed to investigate this regression by injecting and tracing carbon nanoparticles (CNs) into the fusion node prior to NAC in patients with breast cancer.
Guided by ultrasound, 0.3 mL of CNs suspension was injected in the fusion node prior to NAC in 110 patients with local advanced breast cancer. Then the patients underwent breast surgery and total axillary lymph node dissection following 2-6 cycles of NAC. The distribution by intercostobrachial nerves (ICBN) of positive nodes and black-stained nodes was researched, and the relationship between the distribution and lymphovascular invasion were investigated by response to NAC.
When patients were ranked by response to NAC (from sensitive to resistance), the number of positive nodes increased, as did the proportion of lymphovascular invasion, the number of black-stained nodes decreased. A significantly negative relationship was found between the number of positive nodes and the number of black-stained nodes (p < 0.001). The positive nodes in patients with sensitive consequence followed the rule from under the ICBN to above the ICBN. However, there was counter-example (skip metastasis) in the patients with resistance result.
The regression of positive nodes follows the rule from upper to under, inner to outer in the patients with sensitive consequence to NAC. Long-term staining and tracing by CNs might provide an acceptable and feasible technique to investigate the regression of positive nodes, and would be a potential method for NAC-treated patients by using of ICBN.
NCT03355261. Retrospectively registered on November 28, 2017.
新辅助化疗(NAC)后乳腺癌阳性淋巴结的退缩情况尚不清楚。本研究旨在通过在乳腺癌患者 NAC 前向融合淋巴结注射和追踪碳纳米颗粒(CNs)来研究这种退缩情况。
在 110 例局部晚期乳腺癌患者中,在 NAC 前,在超声引导下向融合淋巴结注射 0.3ml 的 CNs 混悬液。然后,患者在接受 2-6 个周期的 NAC 后接受乳房手术和腋窝淋巴结清扫术。研究了阳性淋巴结和黑色染色淋巴结的肋间臂神经(ICBN)分布情况,并通过对 NAC 的反应研究了分布与脉管侵犯之间的关系。
当根据对 NAC 的反应(从敏感到耐药)对患者进行排序时,阳性淋巴结的数量增加,脉管侵犯的比例增加,黑色染色淋巴结的数量减少。阳性淋巴结的数量与黑色染色淋巴结的数量呈显著负相关(p<0.001)。对 NAC 结果敏感的患者的阳性淋巴结遵循从 ICBN 下到 ICBN 上的规律。然而,耐药结果的患者存在反例(跳跃转移)。
对 NAC 结果敏感的患者,阳性淋巴结的退缩遵循从内到外、从下到上的规律。CNs 的长期染色和追踪可能为研究阳性淋巴结的退缩提供一种可接受且可行的技术,并且可能成为使用 ICBN 对 NAC 治疗患者的潜在方法。
NCT03355261. 2017 年 11 月 28 日回顾性注册。